RxDoctor Payments Data

Charles Colvin, MD

Otolaryngology · Birmingham, ALNPI 1811906126

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 144 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 18.0% — the pattern of someone who eats at a lot of different presentations.

$3,480in general payments, 2019–2025

Across 144 payments — averaging $24.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron Healthcare Solutions, Inc.$626
  • Sanofi$523
  • Optinose US, Inc.$469
  • Inspire Medical Systems, Inc.$464
  • GSK$441
  • Intersect ENT, Inc.$268
  • plus $688 from 16 others

What the payments were for

  • Food & beverage$3,480100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,480 in reported general payments places this provider in the 75th percentile of 155 otolaryngology providers in Alabama.

See all otolaryngology providers in Alabama

Medicare billing

Part B allowed, 2024
$126,676
Medicare patients
469
Services billed
1,632

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ipratropium Bromide154$5,463
Epinephrine15$4,303
Fluocinolone Acetonide Oil59$3,588
Ofloxacin58$3,522
Cefdinir108$2,401
Fluticasone Propionate87$1,393
Doxycycline Hyclate115$1,386
Montelukast Sodium89$861
Methylprednisolone77$705
Mupirocin69$552
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip19$328
Azelastine Hcl12$286
Nystatin12$194
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav20$181
Clindamycin Hcl20$159

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Birmingham

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →